State-of-the-art strategies for targeting the DNA damage response in cancer

医学 基因组不稳定性 合成致死 DNA修复 DNA损伤 生物标志物 癌症 第1周 计算生物学 癌症研究 DNA 生物信息学 基因 内科学 遗传学 细胞周期 生物 细胞周期蛋白依赖激酶1
作者
Patrick G. Pilié,Chad Tang,Gordon B. Mills,Timothy A. Yap
出处
期刊:Nature Reviews Clinical Oncology [Nature Portfolio]
卷期号:16 (2): 81-104 被引量:1194
标识
DOI:10.1038/s41571-018-0114-z
摘要

Genomic instability is a key hallmark of cancer that arises owing to defects in the DNA damage response (DDR) and/or increased replication stress. These alterations promote the clonal evolution of cancer cells via the accumulation of driver aberrations, including gene copy-number changes, rearrangements and mutations; however, these same defects also create vulnerabilities that are relatively specific to cancer cells, which could potentially be exploited to increase the therapeutic index of anticancer treatments and thereby improve patient outcomes. The discovery that BRCA-mutant cancer cells are exquisitely sensitive to inhibition of poly(ADP-ribose) polymerase has ushered in a new era of research on biomarker-driven synthetic lethal treatment strategies for different cancers. The therapeutic landscape of antitumour agents targeting the DDR has rapidly expanded to include inhibitors of other key mediators of DNA repair and replication, such as ATM, ATR, CHK1 and CHK2, DNA-PK and WEE1. Efforts to optimize these therapies are ongoing across a range of cancers, involving the development of predictive biomarker assays of responsiveness (beyond BRCA mutations), assessment of the mechanisms underlying intrinsic and acquired resistance, and evaluation of rational, tolerable combinations with standard-of-care treatments (such as chemotherapeutics and radiation), novel molecularly targeted agents and immune-checkpoint inhibitors. In this Review, we discuss the current status of anticancer therapies targeting the DDR. Inhibition of poly(ADP-ribose) polymerase (PARP) is the paradigmatic example of synthetic lethal therapy and is predicated on exploiting DNA repair deficiencies that are a hallmark of cancer. In this Review, the authors review the progress made to date with PARP inhibitors and describe the expanding landscape of novel anticancer therapies targeting the DNA damage response. Potential predictive biomarkers, mechanisms of resistance and combinatorial strategies are discussed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Tong完成签到,获得积分10
1秒前
jiaminzhao完成签到,获得积分10
2秒前
思源的应助被大方的妙梦采纳,获得10
2秒前
2秒前
3秒前
4秒前
落叶发布了新的文献求助10
4秒前
YM发布了新的文献求助10
5秒前
mumu完成签到 ,获得积分10
5秒前
5秒前
Frank发布了新的文献求助10
6秒前
San发布了新的文献求助10
6秒前
英吉利25发布了新的文献求助10
8秒前
仁爱嫣完成签到,获得积分10
8秒前
嘞嘞累哦完成签到,获得积分10
9秒前
ding的应助被陈鸿超采纳,获得10
9秒前
ZRH发布了新的文献求助10
9秒前
jerry完成签到 ,获得积分10
10秒前
斤斤计较发布了新的文献求助10
11秒前
11秒前
11秒前
11秒前
Qingzhu完成签到,获得积分10
13秒前
何糖完成签到 ,获得积分10
13秒前
Maestro_S的应助被感动的樱桃采纳,获得10
13秒前
syvshc的应助被QINYUYU采纳,获得10
15秒前
FashionBoy的应助被likes采纳,获得10
15秒前
15秒前
研友_VZG7GZ的应助被yun采纳,获得30
16秒前
李小晴天完成签到,获得积分10
16秒前
16秒前
可爱玫瑰发布了新的文献求助10
17秒前
18秒前
CodeCraft的应助被dengdeng采纳,获得10
18秒前
Yebo完成签到 ,获得积分10
18秒前
希尔巴德发布了新的文献求助10
18秒前
苹果紫完成签到 ,获得积分10
21秒前
深情安青的应助被18756828852采纳,获得30
22秒前
嘻嘻哈哈的应助被江子川采纳,获得10
22秒前
ttchen的应助被江子川采纳,获得10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192871
求助须知:如何正确求助?哪些是违规求助? 9579281
关于积分的说明 21864358
捐赠科研通 7792445
什么是DOI,文献DOI怎么找? 3437059
关于科研通互助平台的介绍 2560639
邀请新用户注册赠送积分活动 2483928